![]() ![]() Sinopharm's SARS-CoV-2 strain (WIV04 strain and GenBank number ( MN996528) was isolated from a patient in the Jinyintan Hospital, Wuhan, China. In addition, this development technology has been successfully used in many well-known vaccines, such as the rabies vaccine. For several decades, inactivated virus vaccines, such as vaccines against hepatitis A, have been successfully applied. The Sinopharm BBIBP-CorV vaccine teaches the immune system to make antibodies against the SARS-CoV-2 beta coronavirus. ( Sinopharm) and the Beijing Institute of Biological Products Co in 2020. The Sinopharm COVID-19 (BBIBP-CorV, COVILO) is an inactivated vaccine made of virus particles grown in culture and lacks the disease-producing capability. This vaccine was developed by China National Pharmaceutical Group Co., Ltd. Sinopharm COVID-19 Vaccine (BBIBP-CorV) 2022
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |